Wire flash
Hengrui Medicine buys back 335,000 A-shares for first time, spending about 14.5 mln yuan
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
On September 17, 2026, Hengrui Medicine conducted its first share repurchase of A-share stocks via centralized bidding, buying back 335,000 shares, representing 0.005% of its total share capital. The highest transaction price was RMB 43.58 per share and the lowest was RMB 43.10 per share, with a total payment of RMB 14.5036 million. According to the previously disclosed plan, the company intends to use its own funds to repurchase shares for an employee stock ownership plan, with a total repurchase amount ranging from no less than RMB 1 billion to no more than RMB 2 billion. The repurchase period runs from August 19, 2026, to August 18, 2027.
Source report
Jin10 Data, September 17 — Hengrui Medicine announced that on September 17, 2026, the company completed its first repurchase of A-share stocks through centralized bidding transactions.
Repurchase Details
- Shares bought back: 335,000 shares
- Percentage of total share capital: 0.005%
- Highest transaction price: RMB 43.58 per share
- Lowest transaction price: RMB 43.10 per share
- Total payment: RMB 14.5036 million
Background and Plan
According to the previously disclosed plan, the company intends to use its own funds to repurchase shares via centralized bidding for an employee stock ownership plan. The key parameters of the plan are as follows:
- Total repurchase amount: No less than RMB 1 billion and no more than RMB 2 billion
- Repurchase period: From August 19, 2026, to August 18, 2027
Source
金十数据Neutral / independent
Part of this Story
Hengrui Medicine launches first share buyback, repurchasing 335,000 A-shares for 14.5 million yuan